Loading ....
Filter
Sort By
CLS Cell Line
CLS Cell Line
909 Result Found
Sort By : Price - Low to High
-
Human Carcinoma cell line B-LCL-HROC06
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Carcinoma cell line B-LCL-HROC313 (Bc HROC313)
$800- Handling of Proliferating Cultures : One or two cell
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Cryopreserved Cultures : The cells come
-
Human Carcinoma cell line B-LCL-HROC10
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Carcinoma cell line B-LCL-HROC130
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Carcinoma cell line B-LCL-HROC195
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Carcinoma cell line B-LCL-HROC68
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Carcinoma cell line B-LCL-HROC117 (Bc HROC117)
$800- Handling of Proliferating Cultures : One or two cell
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Cryopreserved Cultures : The cells come
-
Human Carcinoma cell line B-LCL-HROC103
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Carcinoma cell line B-LCL-HROC60
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Carcinoma cell line B-LCL-HROC102
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD19
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Human Childhood T acute lymphoblastic leukemia cell line CCRF-CEM-C7
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 2.1
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Tissue : Blood
-
Human Congenital Disorders of Glycosylation cell line B-LCL-CDG2
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD60a- (GD3), C
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Proliferating Cultures : One or two cell
-
Pig cell line PIEC
$800- Handling of Cryopreserved Cultures : The cells come
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Subculturing : Remove medium a
- Fluid Renewal : 2 to 3 times pe
-
Human Carcinoma cell line HeLa Kyoto Mad2-LAP/H2B-mCherry
$800- Handling of Proliferating Cultures : One or two cell
- Protein Expression : Mad2-LAP/H2B-mC
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Cryopreserved Cultures : The cells come
-
Human Oral cavity, tonsil cell line HK
$800- Handling of Cryopreserved Cultures : The cells come
- Surface Antigens : CD14+, CD40+, I
- Medium Supplements : 10% FBS, w: 2 m
- Passaging Solution : Accutase
- Biosafety level : 2
-
Human cell line 293E
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Tissue : Embryonic
-
Rat cell line NRK-EGFP2-Nup50
$800- Subculturing : Remove medium a
- Receptors Expressed : Epidermal growt
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Cryopreserved Cultures : The cells come
-
Rat cell line NRK-4xlambdaN22-3xmEGFP-M9
$800- Subculturing : Remove medium a
- Receptors Expressed : Epidermal growt
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Cryopreserved Cultures : The cells come
-
Rat cell line NRK-Pom121-EGFP3
$800- Subculturing : Remove medium a
- Receptors Expressed : Epidermal growt
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Cryopreserved Cultures : The cells come
-
Human cell line 2V6.11
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 2 m
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Subculturing : Remove medium a
-
Human cell line Wilms1
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Receptors Expressed : Receptor tyrosi
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
-
Pig cell line IBRS-2
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Subculturing : Remove medium a
-
Rat cell line HSC-T6
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS
- Passaging Solution : Accutase
- Biosafety level : 1
- Citation : HSC-T6 (CLS cat
-
Human cell line B-LCL-HROG04
$800- Handling of Proliferating Cultures : One or two cell
- Medium Supplements : 10% heat-inacti
- Passaging Solution : The utilization
- Handling of Cryopreserved Cultures : The cells come
- Subculturing : Resuspend cell
-
Human Thyroid gland anaplastic carcinoma cell line KHM-5M
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 2.1
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Subculturing : Remove medium a
-
Human Thyroid gland anaplastic carcinoma cell line KMH-2
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 2.1
- Passaging Solution : Accutase
- Biosafety level : 1
- Citation : KMH-2 (CLS cata
-
Human Wilms Tumor cell line imWilms1
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Human Wilms Tumor cell line ImWilms10T
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Human Wilms tumor cell line Wilms3
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Human Wilms tumor cell line Wilms8
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Human Wilms tumor cell line Wilms6
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Human Wilms tumor cell line Wilms2
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Human Wilms tumor cell line Wilms11
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Human Wilms tumor cell line Wilms10T
$800- Handling of Cryopreserved Cultures : The cells come
- Mutational Profile : WT1 mutation st
- Medium Supplements : 4 mM L-glutamin
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
-
Mouse cell line HT22
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Subculturing : Remove medium a
-
Cercopithecus aethiops cell line MARC-145
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Subculturing : Remove medium a
-
Human Melanoma cell line A875
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, w: 4.5
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Subculturing : Remove medium a
-
Mouse Mouse pancreatic ductal adenocarcinoma cell line Panc02
$800- Handling of Cryopreserved Cultures : The cells come
- Medium Supplements : 10% FBS, 2.0 mM
- Passaging Solution : Accutase
- Handling of Proliferating Cultures : One or two cell
- Tissue : Pancreas
-
Human Primary adenocarcinoma, TNM stage , grading cell line HROC24 T3 M1 #2
$800- Handling of Cryopreserved Cultures : The cells come
- Ploidy Status : euploid
- Medium Supplements : 5% FBS, w: 3.1
- Passaging Solution : Accutase
- Biosafety level : 1
-
A549/DDP Cells
$1500- Organism : Human
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : Remove the old
- Medium Supplements : Supplement the
-
HEK293-CCR8 Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
HEK293-FOLR1 Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
HEK293-TACD2 Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
HEK293-CTLA4 Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
HEK293-HER2 Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
HEK293-CXCR7 Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
HEK293-CXCR4 Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
HEK293-FAP Cells
$5000- Growth Properties : adherent
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : Supplement the
-
CHO-CCR8 Cells
$5000- Growth Properties : Suspension
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : For adherent cu
-
CHO-B7H3 Cells
$5000- Growth Properties : Suspension
- Freezing Recovery : Confirm that th
- Fluid Renewal : 2 to 3 times pe
- Subculturing : For routine adh
- Medium Supplements : For adherent cu
ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.
© 2026 Biohippo. All rights reserved.